Literature DB >> 14171763

PHARMACOLOGICAL PROPERTIES OF A MINERALOCORTICOID ANTAGONIST (SC-14266).

C M KAGAWA, D J BOUSKA, M L ANDERSON, W F KROL.   

Abstract

Entities:  

Keywords:  ALDOSTERONE ANTAGONISTS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DIURESIS; ENDOCRINE GLANDS; EXPERIMENTAL LAB STUDY; PHARMACOLOGY; RATS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14171763

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  8 in total

1.  Antagonism of fludrocortisone by spironolactone and canrenone.

Authors:  G J Huston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  Canrenoate disposition in dogs. Tissue distribution and elimination.

Authors:  J Kuhlmann; V Kötter; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

3.  Canrenone--the principal active metabolite of spironolactone?

Authors:  L E Ramsay; J R Shelton; D Wilkinson; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  A comparison of some extra-renal effects of spironolactone and canrenone.

Authors:  G J Huston; E A Al-Dujaili
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

5.  Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.

Authors:  W Sadée; U Abshagen; C Finn; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.

Authors:  G T McInnes; J R Shelton; L E Ramsay; I R Harrison; M J Asbury; J M Clarke; R M Perkins; G R Venning
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

7.  The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol.

Authors:  M D Fernandez; G D Carter; T N Palmer
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

8.  Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304).

Authors:  D Marver; J Stewart; J W Funder; D Feldman; I S Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.